Filter News
Area of Research
- (-) National Security (17)
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (29)
- Clean Energy (19)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (1)
- Fusion and Fission (3)
- Isotopes (23)
- Materials (23)
- Materials for Computing (3)
- Neutron Science (15)
- Sensors and Controls (1)
- Supercomputing (41)
News Type
News Topics
- (-) Artificial Intelligence (12)
- (-) Biomedical (3)
- (-) Isotopes (4)
- (-) Security (10)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (7)
- Big Data (4)
- Bioenergy (4)
- Biology (5)
- Biotechnology (1)
- Buildings (1)
- Chemical Sciences (2)
- Climate Change (5)
- Computer Science (19)
- Coronavirus (2)
- Cybersecurity (17)
- Decarbonization (3)
- Energy Storage (1)
- Environment (4)
- Exascale Computing (1)
- Frontier (1)
- Fusion (8)
- Grid (4)
- High-Performance Computing (4)
- Machine Learning (12)
- Materials (2)
- Materials Science (6)
- Molten Salt (1)
- Nanotechnology (1)
- National Security (33)
- Neutron Science (6)
- Nuclear Energy (27)
- Partnerships (4)
- Physics (3)
- Quantum Science (1)
- Simulation (1)
- Space Exploration (3)
- Summit (1)
- Sustainable Energy (3)
- Transformational Challenge Reactor (3)
- Transportation (1)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.